LegalizeCommission Implementing Regulation (EU) 2025/544 of 25 March 2025 amending Implementing Regulation (EU) 2021/403 as regards model animal health certificates and model animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof
This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.
| COUNTRY | Animal health/official certificate to the EU |
| --- | --- |
| I.1 | Consignor/Exporter |
| Name | |
| Address | |
| Address | |
| Country | |
| I.5 | Consignee/Importer |
| Name | |
| Address | |
| Country | |
| I.7 | Country of origin |
| I.8 | Region of origin |
| I.11 | Place of dispatch |
| Name | |
| Address | |
| Country | |
| I.13 | Place of loading |
| --- | --- |
| I.15 | Means of transport |
| ☐ Aircraft | |
| ☐ Railway | |
| Identification | |
| Identification | |
| --- | --- |
| I.18 | |
| I.19 | Container number/Seal number |
| Container No | |
| I.20 | Certified as or for |
| ☐ Slaughter | |
| --- | --- |
| I.21 | |
| --- | --- |
| I.24 | |
| --- | --- |
| I.27 | Description of consignment |
| CN code | Species |
Part II: Certification
| COUNTRY | COUNTRY | Certificate model BOV-Y | Certificate model BOV-Y | Certificate model BOV-Y | Certificate model BOV-Y |
| II. Health information | II.a | Certificate reference | II.b | IMSOC reference |
| II.1. Public health attestation I, the undersigned official veterinarian, hereby certify, that the animals described in Part I: II.1.1. have not received: (a) any stilbene or thyrostatic substances; (b) oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC); II.1.2. fulfil the guarantees provided by the control plan submitted in accordance with Article 6(2) of Commission Delegated Regulation (EU) 2022/2292, and the third country or region thereof of their origin is listed in Annex –I to Commission Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “bovine”; II.1.3. with regard to bovine spongiform encephalopathy (BSE), (a) the animals are identified by a permanent identification system enabling them to be traced back to the dam and herd of origin, and they are not: (i) BSE cases; (ii) bovine animals which, during their first year of life, were reared with BSE cases during their first year of life, and which an investigation has shown that they have consumed the same potentially contaminated feed during that period, or (iii) if the results of the investigation referred to in point (ii) are inconclusive, bovine animals which, during their first year of life, were reared with BSE cases during their first year of life, or were born in the same herd as, and within 12 months preceding or following the date of the birth of, the BSE cases; (1) either [(b) (i) the animals were born and continuously reared in a country or region thereof or countries or regions thereof classified in accordance with Commission Decision 2007/453/EC as countries or regions posing a negligible BSE risk; (ii) if there have been BSE indigenous cases in the country concerned, the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, was effectively enforced, or they were born after the date of birth of the last BSE indigenous case if born after the date of the feed ban.] (1) or [(b) (i) the country or region thereof of origin of the animals is classified in accordance with Decision 2007/453/EC as a country or region thereof posing a controlled BSE risk; (ii) the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, was effectively enforced, or they were born after the date of birth of the last BSE indigenous case if born after the date of the feed ban.] (1) or [(b) (i) the country or region thereof of origin of the animals is classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk; (ii) the feeding of ruminants with meat-and-bone meal and greaves from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and the ban has been effectively enforced in the country or region thereof of origin; (iii) the animals were born at least 2 years after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, was effectively enforced, or they were born after the date of birth of the last BSE indigenous case if born after the date of the feed ban.] (1) (13) [II.1a. Attestation as regards Commission Delegated Regulation (EU) 2023/905 I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Commission Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.] II.2. Animal health attestation I, the undersigned official veterinarian, hereby certify that the animals described in Part I: II.2.1. come from the zone with code - (2) which, at the date of issue of this animal health/official certificate is authorised for the entry into the Union of bovine animals intended for slaughter and is listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2021/404; II.2.2. are intended for slaughter in the Union; II.2.3. have remained continuously: (a) in the zone referred to in point II.2.1 since birth or for at least 3 months prior to the date of their dispatch to the Union, and (b) in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during this period no bovine animals and no animals of other species listed for the same diseases as bovine animals have been introduced; II.2.4. had no contact with animals of a lower health status since birth or for at least 30 days prior to the date of their dispatch to the Union; II.2.5. are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; (1) either [II.2.6. have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;] (1) or [II.2.6. have undergone one single assembly operation in the zone of origin fulfilling the following requirements: (a) the assembly operation took place in an establishment: (i) approved for conducting assembly operations of ungulates by the competent authority in the third country or territory in accordance with Article 5 of Commission Delegated Regulation (EU) 2019/2035; (ii) which has a unique approval number assigned by the competent authority of the third country or territory; (iii) listed for that purpose by the competent authority of the third country or territory of dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035; (iv) fulfilling the requirements provided for in Article 8 of Commission Delegated Regulation (EU) 2020/692; (b) the assembly operation in the assembly centre took no longer than 6 days;] II.2.7. have not been unloaded in any place that does not comply with the requirements laid down in point II.2.12 since the date of their dispatch from their establishment of origin until the date of loading for dispatch to the Union and during that period they have not been in contact with animals of a lower health status; II.2.8. are loaded for dispatch to the Union on //_ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory and constructed in such a way that: (a) animals cannot escape or fall out; (b) visual inspection of the space where animals are kept is possible; (c) the escape of animal excrements, litter or feed is prevented or minimized; II.2.9. have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory, of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.2.10. have not been vaccinated against: (a) foot and mouth disease, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia), infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) and infection with Brucella abortus, B. melitensis and B. suis, and (b) infection with bluetongue virus (serotypes 1-24) with a live vaccine during the last 60 days prior to the date of their dispatch to the Union; II.2.11. come from a zone II.2.11.1. in which: (a) foot and mouth disease has not been reported (1) either [for at least 24 months prior to the date of dispatch of the animals to the Union;] (1) (4) or [since _//____ (dd/mm/yyyy);] (b) vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period; II.2.11.2. in which infection with lumpy skin disease virus has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union; II.2.11.3. in which infection with rinderpest virus, infection with Rift Valley fever virus and infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and during that period: (a) vaccination against these diseases has not been carried out, and (b) the animals vaccinated against these diseases have not been introduced; (1) (5) either [II.2.11.4. which is free from infection with bluetongue virus (serotypes 1-24);] (1) or [II.2.11.4. which is seasonally free from infection with bluetongue virus (serotypes 1-24) (1) (6) either [for at least 60 days prior to the date of dispatch of the animals to the Union;] (1) (6) or [for at least 28 days prior to the date of dispatch of the animals to the Union and the animals have been subjected to a serological test in accordance with Article 9, point (b), of Delegated Regulation (EU) 2020/692, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally free zone;] (1) (6) or [for at least 14 days prior to the date of dispatch of the animals to the Union and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals in the seasonally free zone;] (1) or [II.2.11.4. which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been vaccinated against all the serotypes (1- 24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch of the animals to the Union and are still within the immunity period guaranteed in the specifications of the vaccine, and (1) either [have been vaccinated more than 60 days prior to the date of dispatch of the animals to the Union;]] (1) or [have been vaccinated with an inactivated vaccine and were subjected to a PCR test, with negative results on samples collected at least 14 days after the date of onset of the immunity protection set in the specifications of the vaccine;]] (1) or [II.2.11.4. which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes (1-24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch of the animals to the Union, and (1) either [the serological test has been carried out on samples collected at least 60 days prior to the date of dispatch of the animals to the Union;]] (1) or [the serological test has been carried out on samples collected at least 30 days prior to the date of dispatch of the animals to the Union and the animals were subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of dispatch of the animals to the Union;]] (1) (7) either [II.2.11.5. which is free from enzootic bovine leukosis;] (1) or [II.2.11.5. which is not free from enzootic bovine leukosis and the disease has not been reported in the establishment of origin of the animals during at least 24 months prior to the date of dispatch of the animals to the Union, and: [II.2.11.5.1. the animals of the consignment over 24 months of age (1) either [have been kept in isolation from the other bovine animals kept in the same establishment prior to the date of dispatch to the Union and during the period of isolation have been subjected to a laboratory examination for enzootic bovine leukosis using one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, carried out on samples taken on two occasions at an interval of at least 4 months;]] (1) or [have been subjected to a laboratory examination for enzootic bovine leukosis using one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, carried out on a sample taken during the last 30 days prior to the date of their dispatch to the Union and all bovine animals over 24 months of age kept in the establishment of origin have been subjected to a laboratory examination for enzootic bovine leukosis with one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, carried out, with negative results, on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of dispatch of the animals to the Union;]] (1) [II.2.11.5.2. the animals of the consignment younger than 24 months of age were born to dams which have been subjected to a laboratory examination for enzootic bovine leukosis with one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, carried out on samples taken on two occasions at an interval of not less than 4 months during the last 12 months prior to the date of dispatch of the animals to the Union;]] II.2.12. come from an establishment: II.2.12.1. which is registered by and under the control of the competent authority of the third country or territory of origin and has a system in place to maintain for at least 3 years following the date of dispatch of the animals to the Union the up-to-date records containing information regarding: (a) the species, categories, number and identification of animals on the establishment; (b) movements of animals into and out of the establishment; (c) mortality in the establishment; II.2.12.2. which receives regular animal health visits from a veterinarian for the purpose of the detection of, and information on, signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at a frequency that is proportional to the risk posed by the establishment; II.2.12.3. which was not subject to national restriction measures for animal health reasons, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to the Union; II.2.12.4. in and around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) and infection with lumpy skin disease virus; (1) either [II.2.12.5. in and around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;] (1) (8) or [II.2.12.5. which is located in a zone seasonally free of epizootic haemorrhagic disease;] (1) (9) [II.2.12.6. which is free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) as regards bovine animals;] (1) (9) [II.2.12.7. which is free from infection with Brucella abortus, B. melitensis and B. suis as regards bovine animals;] II.2.12.8. in which infection with rabies virus has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union; II.2.12.9. in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union; (1) either [II.2.12.10. in which surra (Trypanosoma evansi) has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;] (1) or [II.2.12.10. in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union and when the disease was reported in the establishment of origin during the last 2 years prior to the date of dispatch of the animals to the Union, the affected establishment remained under restriction until the date on which the infected animals were removed from the establishment and the date on which the remaining animals on the establishment were subjected with negative result to a test for surra as described in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 carried out on samples taken at least 6 months after the date on which the infected animals were removed from the establishment;] (1) (10) [II.2.13. have not been vaccinated against infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and (1) (11) either [originate from a third country or territory or zone thereof free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]] (1) or [have been kept in quarantine for at least 30 days prior to the date of their dispatch to the Union and have undergone a serological test for the detection of antibodies against whole bovine herpes virus-1 (BoHV-1) with one of the diagnostic methods referred to in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692, with negative results, on a sample taken within the last 15 days prior to the date of dispatch of the animals to the Union;]] (1) (10) [II.2.14. have not been vaccinated against bovine viral diarrhoea, and (1) (12) either [originate from a third country or territory, or zone thereof free from bovine viral diarrhoea.]] (1) or [have been tested for bovine viral diarrhoea virus antigen or genome using one of the diagnostic methods provided for in Part 6 of Annex I to Commission Delegated Regulation (EU) 2020/688 with negative results, and (1) either [have been kept in a quarantine establishment for at least 21 days prior to the date of their dispatch to the Union.]]] (1) or [are pregnant dams and have been kept in a quarantine establishment for at least 21 days prior to the date of their dispatch to the Union and have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688 with negative results carried out on samples taken not less than 21 days after the date of commencement of the quarantine.]]] (1) or [have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results, carried out on samples taken prior to the date of their dispatch to the Union.]]] (1) or [are pregnant dams that have been subjected to a serological test for the detection of antibodies against bovine viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of Annex I to Delegated Regulation (EU) 2020/688, with positive results, carried out on samples taken prior to the date of insemination preceding the date of current gestation.]] Notes: This animal health/official certificate is intended for the entry of bovine animals that will be slaughtered in the Union. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health/official certificate include the United Kingdom in respect of Northern Ireland. This animal health/official certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692. Part II: (1) Delete if not applicable. (2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (3) Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone. (4) Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (5) For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex I to Implementing Regulation (EU) 2021/404. (6) For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (7) For the zones with an entry “EBL” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (8) For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (9) In accordance with Article 10 of Delegated Regulation (EU) 2020/692. (10) Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement between the European Community and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002, p.132), either have disease-free status or an approved eradication programme for the diseases mentioned in points II.2.12 and II.2.13 (infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and bovine viral diarrhoea). (11) For the zones with an entry “IBR” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (12) For the zones with an entry “BVD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (13) Applicable to consignments entering the Union as from 3 September 2026. |
| Official veterinarian | Official veterinarian |
| Name (in capital letters) | |
| Date | Qualification and title |
| Stamp | Signature |
CHAPTER 3
MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF BOVINE ANIMALS INTENDED FOR TRANSIT FROM THE REGION OF KALININGRAD TO OTHER REGIONS OF RUSSIA VIA THE TERRITORY OF LITHUANIA (MODEL “BOV-X-TRANSIT-RU”)
Part I: Description of consignment
| COUNTRY | Animal health certificate to the EU |
| --- | --- |
| I.1 | Consignor/Exporter |
| Name | |
| Address | |
| Address | |
| Country | |
| I.5 | Consignee/Importer |
| Name | |
| Address | |
| Country | |
| I.7 | Country of origin |
| I.8 | Region of origin |
| I.11 | Place of dispatch |
| Name | |
| Address | |
| Country | |
| I.13 | Place of loading |
| --- | --- |
| I.15 | Means of transport |
| ☐ Aircraft | |
| ☐ Railway | |
| Identification | |
| Identification | |
| --- | --- |
| I.18 | |
| I.19 | Container number/Seal number |
| Container No | |
| I.20 | Certified as or for |
| --- | --- |
| I.21 | ☐ For transit |
| Third country | |
| --- | --- |
| I.24 | |
| --- | --- |
| I.27 | Description of consignment |
| CN code | Species |
Part II: Certification
| COUNTRY | COUNTRY | Certificate model BOV-X-TRANSIT-RU | Certificate model BOV-X-TRANSIT-RU | Certificate model BOV-X-TRANSIT-RU | Certificate model BOV-X-TRANSIT-RU |
| II. Health information | II.a | Certificate reference | II.b | IMSOC reference |
| II.1. Animal health attestation I, the undersigned official veterinarian, hereby certify that the animals described in Part I: II.1.1. come from the zone with code RU-2 (2) which, at the date of issuing this animal health certificate is listed in Part 1 of Annex XXII to Commission Implementing Regulation (EU) 2021/404 for transit of bovine animals through the Union under specific conditions; (1) either [II.1.2. originate from the Union and they were introduced from the Union into the zone with code RU-2 on _//_ (dd/mm/yyyy) and, since that date, they have been kept in facilities where only animals that originate from the Union are kept;] (1) or [II.1.2. have remained in the zone with code RU-2 since birth, or for at least 6 months prior to the date of dispatch to Russia via the Union and without contact with imported animals for the last 30 days prior the date of their dispatch to Russia via the Union;] II.1.3. had no contact with animals not complying with the animal health requirements as described in this animal health certificate; II.1.4. are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.5. have not been unloaded in any place that does not comply with the requirements laid down in point II.1.10 since the date of dispatch from their establishment of origin until the date of their dispatch to Russia via the Union and during that period they have not been in contact with animals of a lower health status; II.1.6. are loaded for dispatch to Russia via the Union on // (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority of the third country or territory and constructed in such a way that: (a) animals cannot escape or fall out; (b) visual inspection of the space where animals are kept is possible; (c) the escape of animal excrements, litter or feed is prevented or minimized; II.1.7. have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to Russia via the Union, carried out by an official veterinarian, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.8. have not been vaccinated against: (a) foot and mouth disease, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia), and (b) infection with bluetongue virus (serotypes 1-24) with a live vaccine during the 60 days prior to the date of their dispatch to Russia via the Union; II.1.9. come from the zone described in point II.1.1: II.1.9.1. in which: (a) foot and mouth disease has not been reported (1) either [for at least 24 months prior to the date of dispatch to Russia via the Union;] (1) (4) or [since //____ (dd/mm/yyyy);] (b) vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to Russia via the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period; II.1.9.2. in which infection with lumpy skin disease virus has not been reported for at least 12 months prior to the date of dispatch to Russia via the Union; II.1.9.3. in which infection with rinderpest virus, infection with Rift Valley fever virus and infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) has not been reported for at least 12 months prior to the date of dispatch to Russia via the Union and during that period: (a) vaccination against these diseases has not been carried out, and (b) the animals vaccinated against these diseases have not been introduced; (1) (5) either [II.1.9.4. which is free from infection with bluetongue virus (serotypes 1-24);] (1) or [II.1.9.4. which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been vaccinated against all the serotypes (1-24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch to Russia via the Union and are still within the immunity period guaranteed in the specifications of the vaccine and have been vaccinated more than 60 days prior to the date of dispatch of the animals to Russia via the Union;] II.1.10. come from the establishment described under box reference I.11 [where they have remained since birth or for at least 40 days prior to the date of dispatch to Russia via the Union, and] (6): II.1.10.1. which was not subject to national restriction measures for animal health reasons, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to Russia via the Union; II.1.10.2. in and around which, in an area of 10 km radius none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to Russia via the Union: foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with Mycoplasma mycoides subsp. mycoides SC (Contagious bovine pleuropneumonia) and infection with lumpy skin disease virus; II.1.10.3. in and around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 60 days prior to the date of dispatch of the animals to Russia via the Union. Notes: In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692. Part II: (1) Delete if not applicable. (2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex XXII to Implementing Regulation (EU) 2021/404. (3) Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for transit to Russia through the Union, or in a period when restriction measures have been adopted by the Union against such transit of those animals from that zone. (4) Only for the zones with an opening date in column 8 of the table in Part 1 of Annex XXII to Implementing Regulation (EU) 2021/404. (5) For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex XXII to Implementing Regulation (EU) 2021/404. (6) Delete the text in square brackets if the second option of point II.1.2 is deleted. |
| Official veterinarian | Official veterinarian |
| Name (in capital letters) | |
| Date | Qualification and title |
| Stamp | Signature |
CHAPTER 4
MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF OVINE AND CAPRINE ANIMALS (MODEL “OV/CAP-X”)
Part I: Description of consignment
| COUNTRY | Animal health/official certificate to the EU |
| --- | --- |
| I.1 | Consignor/Exporter |
| Name | |
| Address | |
| Address | |
| Country | |
| I.5 | Consignee/Importer |
| Name | |
| Address | |
| Country | |
| I.7 | Country of origin |
| I.8 | Region of origin |
| I.11 | Place of dispatch |
| Name | |
| Address | |
| Country | |
| I.13 | Place of loading |
| --- | --- |
| I.15 | Means of transport |
| ☐ Aircraft | |
| ☐ Railway | |
| Identification | |
| Identification | |
| --- | --- |
| I.18 | |
| I.19 | Container number/Seal number |
| Container No | |
| I.20 | Certified as or for |
| ☐ Further keeping | |
| --- | --- |
| I.21 | ☐ For transit |
| Third country | |
| --- | --- |
| I.24 | Total number of packages |
| --- | --- |
| I.27 | Description of consignment |
| CN code | Species |
Part II: Certification
| COUNTRY | COUNTRY | Certificate model OV/CAP-X | Certificate model OV/CAP-X | Certificate model OV/CAP-X | Certificate model OV/CAP-X |
| II. Health information | II.a | Certificate reference | II.b | IMSOC reference |
| (1) [II.1. Public health attestation (Delete when the Union is not the final destination of the animals) I, the undersigned official veterinarian, hereby certify, that the animals described in Part I: II.1.1. have not received: (a) any stilbene or thyrostatic substances; (b) oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than therapeutic or zootechnical treatment (as defined in Council Directive 96/22/EC); II.1.2. fulfil the guarantees provided by the control plan submitted in accordance with Article 6(2) of Commission Delegated Regulation (EU) 2022/2292, and the third country or region thereof of their origin is listed in Annex –I to Commission Implementing Regulation (EU) 2021/405 and marked with an “X” for the category “ovine/caprine”.] (1) (12) [II.1.a. Attestation as regards Commission Delegated Regulation (EU) 2023/905 (Delete when the Union is not the final destination of the animals) I, the undersigned official veterinarian, hereby certify that the animals described in Part I have not been administered antimicrobial medicinal products for growth promotion or yield increase or antimicrobial medicinal products containing an antimicrobial that is included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255, as set out in Article 3 of Commission Delegated Regulation (EU) 2023/905 and originate from a third country or region thereof listed in the Annex to Commission Implementing Regulation (EU) 2024/2598.] II.2. Animal health attestation I, the undersigned official veterinarian, hereby certify that the animals described in Part I: II.2.1. come from the zone with code - (2) which, at the date of issue of this animal health/official certificate is authorised for the entry into the Union of ovine and caprine animals and listed in Part 1 of Annex I to Commission Implementing Regulation (EU) 2021/404; II.2.2. have remained continuously: (a) in the zone referred to in point II.2.1 since birth or for at least 6 months prior to the date of their dispatch to the Union, and (b) in the establishment of origin since birth or for at least 40 days prior to the date of their dispatch to the Union, into which during that period no ovine and caprine animals and no animals of other species listed for the same diseases as ovine and caprine animals have been introduced; II.2.3. had no contact with animals of a lower health status since birth or for at least 30 days prior to the date of their dispatch to the Union; II.2.4. are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I of Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; (1) either [II.2.5. have been dispatched to the Union directly from the establishment of origin without passing through any other establishment;] (1) or [II.2.5. have undergone one single assembly operation in the zone of origin fulfilling the following requirements: (a) the assembly operation took place in an establishment: (i) approved for conducting assembly operations of ungulates by the competent authority in the third country or territory in accordance with Article 5 of Commission Delegated Regulation (EU) 2019/2035; (ii) which has a unique approval number assigned by the competent authority of the third country or territory; (iii) listed for that purpose by the competent authority of the third country or territory of dispatch, including the information set out in Article 21 of Delegated Regulation (EU) 2019/2035; (iv) fulfilling the requirements provided for in Article 8 of Delegated Regulation (EU) 2020/692; (b) the assembly operation in the assembly centre took no longer than 6 days;] II.2.6. have not been unloaded in any place that does not comply with the requirements laid down in point II.2.11 since the date of dispatch from their establishment of origin until the date of loading for dispatch to the Union and during that period have not been in contact with animals of a lower health status; II.2.7. are loaded for dispatch to the Union on //_ (dd/mm/yyyy) (3) in a means of transport which was cleaned and disinfected prior to loading for dispatch with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that: (a) animals cannot escape or fall out; (b) visual inspection of the space where animals are kept is possible; (c) the escape of animal excrements, litter or feed is prevented or minimized; II.2.8. been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.2.9. have not been vaccinated against: (a) foot and mouth disease, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox, contagious caprine pleuropneumonia, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) and infection with Brucella abortus, B. melitensis and B. suis, and (b) infection with bluetongue virus (serotypes 1-24) with a live vaccine during the last 60 days prior to the date of their dispatch to the Union; II.2.10. come from a zone: II.2.10.1. in which: (a) foot and mouth disease has not been reported (1) either [for at least 24 months prior to the date of dispatch to the Union;] (1) (4) or [since _//____ (dd/mm/yyyy);] (b) vaccination against foot and mouth disease has not been carried out for at least 12 months prior to the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth disease have been introduced during that period; II.2.10.2. in which infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has not been reported for at least 12 months prior to the date of dispatch of the animals to the Union and during that period: (a) vaccination against these diseases has not been carried out, and (b) animals vaccinated against these diseases have not been introduced; (1) (5) either [II.2.10.3. which is free from infection with bluetongue virus (serotypes 1-24);] (1) or [II.2.10.3. which is seasonally free from infection with bluetongue virus (serotypes 1-24) (1) (6) either [for at least 60 days prior to the date of dispatch of the animals to the Union;]] (1) (6) or [for at least 28 days prior to the date of dispatch of the animals to the Union and the animals have been subjected to a serological test in accordance with Article 9, point (b), of Commission Delegated Regulation (EU) 2020/692, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally free zone;]] (1) (6) or [for at least 14 days prior to the date of dispatch of the animals to the Union and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals in the seasonally free zone;]] (1) or [II.2.10.3. which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been vaccinated against all the serotypes (1-24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch of the animals to the Union and are still within the immunity period guaranteed in the specifications of the vaccine, and (1) either [have been vaccinated more than 60 days prior to the date of dispatch of the animals to the Union;]] (1) or [have been vaccinated with an inactivated vaccine and were subjected to a PCR test, with negative results on samples collected at least 14 days after the date of onset of the immunity protection set in the specifications of the vaccine;]] (1) or [II.2.10.3. which is not free from infection with bluetongue virus (serotypes 1-24) and the animals have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes (1-24) of bluetongue virus reported in that zone during the last 2 years prior to the date of dispatch of the animals to the Union, and (1) either [the serological test has been carried out on samples collected at least 60 days prior to the date of dispatch of the animals to the Union;]] (1) or [the serological test has been carried out on samples collected at least 30 days prior to the date of dispatch of the animals to the Union and the animals were subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of dispatch of the animals to the Union;]] II.2.11. come from an establishment: II.2.11.1. which is registered by and under the control of the competent authority of the third country or territory of origin and has a system in place to maintain for at least 3 years following the date of dispatch of the animals to the Union the up-to-date records containing information regarding: (a) the species, categories, number and identification of animals on the establishment; (b) movements of animals into and out of the establishment; (c) mortality in the establishment; II.2.11.2. which receives regular animal health visits from a veterinarian for the purpose of the detection of, and information on, signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at a frequency that is proportional to the risk posed by the establishment; II.2.11.3. which was not subject to national restriction measures for animal health reasons, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to the Union; II.2.11.4. in and around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia; (1) either [II.2.11.5. in and around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;] (1) (7) or [II.2.11.5. which is located in a zone seasonally free of epizootic haemorrhagic disease;] (1) (8) either [II.2.11.6. in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported for a at least 42 days prior to the date of dispatch of the animals to the Union;] (1) (9) or [II.2.11.6. which is subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals in accordance with the procedures set out in Part 1, points (1) and (2), of Annex II to Commission Delegated Regulation (EU) 2020/688 for at least 12 months prior to the date of dispatch to the Union of the animals described in Part I and during that period: (a) only caprine animals from establishments applying such surveillance have been introduced therein; (1) either [(b) infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in caprine animals kept therein;]] (1) or [(b) infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept therein and measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688;]] (10) II.2.11.7. which is free from infection with Brucella abortus, B. melitensis and B. suis as regards ovine and caprine animals; and (1) (11) either [in a zone free from the disease as regards ovine and caprine animals where vaccination against that disease is not practised;] (1) or [the animals have been tested with one of the diagnostic methods provided for in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 for infection with Brucella abortus, B. melitensis and B. suis, with negative results, on a sample taken during the last 30 days prior to the date of dispatch to the Union, and in the case of post-parturient females, the test is carried out on a sample taken at least 30 days after the date of parturition;] (1) or [the animals are less than 6 months old;] (1) or [the animals are castrated;] II.2.11.8. in which rabies has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union; II.2.11.9. in which anthrax has not been reported for at least 15 days prior to the date of dispatch of the animals to the Union; (1) either [II.2.11.10. in which surra (Trypanosoma evansi) has not been reported for at least 2 years prior to the date of dispatch of the animals to the Union;] (1) or [II.2.11.10. in which surra (Trypanosoma evansi) has not been reported for at least 30 days prior to the date of dispatch of the animals to the Union and where that disease was reported in the establishment of origin during the last 2 years prior to the date of dispatch of the animals to the Union, the affected establishment remained under restrictions until the date on which the infected animals were removed from the establishment and the date on which the remaining animals on the establishment were subjected with negative results to a test for surra as described in Article 9, point (b)(i), of Delegated Regulation (EU) 2020/692 carried out on samples taken at least 6 months after the date on which the infected animals were removed from the establishment;] (1) (9) [II.2.11.11. in which Burkholderia mallei (glanders) has not been reported for at least 6 months prior to the date of dispatch of the animals to the Union;] II.2.12. comply with the following conditions as regards classical scrapie: II.2.12.1. have been kept continuously since birth in a country where the following conditions are fulfilled: (a) classical scrapie is compulsorily notifiable; (b) an awareness, surveillance and monitoring system is in place; (c) ovine and caprine animals affected with classical scrapie are killed and completely destroyed; (d) the feeding to ovine and caprine animals of meat-and-bone meal or greaves of ruminant origin, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and effectively enforced in the whole country for at least 7 years prior to the date of issuing of this animal health/official certificate; (1) either [II.2.12.2. are intended for production and they are destined for a Member State other than a Member State with a negligible risk status for classical scrapie approved in accordance with Chapter A, Section A, point 2.2, of Annex VIII to Regulation (EC) No 999/2001, or other than a Member State which is listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme;] (1) or [II.2.12.2. are intended for breeding and they are destined for a Member State other than a Member State with a negligible risk status for classical scrapie approved in accordance with Chapter A, Section A, point 2.2, of Annex VIII to Regulation (EC) No 999/2001, or other than a Member State which is listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme, and (1) either [come from a holding or holdings that have complied with the requirements laid down in Chapter A, Section A, point 1.3, of Annex VIII to Regulation (EC) No 999/2001;]] (1) or [are ovine animals of the ARR/ARR prion protein genotype or caprine animals carrying at least one of the K222, D146 or S146 alleles, and they come from a holding or holdings where no official movement restriction has been imposed due to BSE or classical scrapie for the last 2 years prior to the date of issuing of this animal health/official certificate;]] (1) or [II.2.12.2. are destined for a Member State with a negligible risk status for classical scrapie approved in accordance with Chapter A, Section A, point 2.2, of Annex VIII to Regulation (EC) No 999/2001, or for a Member State listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme, and (1) either [come from a holding or holdings that have complied with the requirements laid down in Chapter A, Section A, point 1.2, of Annex VIII to Regulation (EC) No 999/2001;]] (1) or [are ovine animals of the ARR/ARR prion protein genotype or caprine animals carrying at least one of the K222, D146 or S146 alleles, and they come from a holding or holdings where no official movement restriction has been imposed due to BSE or classical scrapie for the last 2 years prior to the date of issuing of this animal health/official certificate;]] (1) [II.2.13. include uncastrated males of ovine animals, which have remained during the period of at least 30 days prior to the date of their dispatch to the Union in an establishment where ovine epididymitis (Brucella ovis) has not been reported during the last 12 months prior to the date of their dispatch to the Union and have been subjected to a serological test for ovine epididymitis (Brucella ovis), with negative results, during the last 30 days prior to the date of their dispatch to the Union.] Notes: This animal health/official certificate is intended for the entry into the Union of ovine and caprine animals, including when the Union is not the final destination of the animals. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health/official certificate include the United Kingdom in respect of Northern Ireland. This animal health/official certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692. Part II: (1) Delete if not applicable. (2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (3) Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.2.1 for the entry into the Union, or in a period when restriction measures have been adopted by the Union against entry into the Union of those animals from that zone. (4) Only for the zones with an opening date in column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (5) For the zones with an entry “BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (6) For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (7) For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (8) Only for ovine animals. (9) Only for caprine animals. (10) In accordance with Article 10 of Delegated Regulation (EU) 2020/692. (11) For the zones with an entry “BRU” for ovine and caprine animals in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. (12) Applicable to consignments entering the Union as from 3 September 2026. |
| Official veterinarian | Official veterinarian |
| Name (in capital letters) | |
| Date | Qualification and title |
| Stamp | Signature |
CHAPTER 5
MODEL ANIMAL HEALTH/OFFICIAL CERTIFICATE FOR THE ENTRY INTO THE UNION OF OVINE AND CAPRINE ANIMALS INTENDED FOR SLAUGHTER (MODEL “OV/CAP-Y”)
Part I: Description of consignment
Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.
This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence.
EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.